![Andrea Kistner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrea Kistner
Financieel Directeur/CFO bij Castle Creek Biosciences, Inc.
Profiel
Andrea Kistner is currently the Vice President-Finance at Castle Creek Biosciences, Inc. She previously worked as a Partner at Roxiticus Ventures LLC from 2001 to 2006.
Actieve functies van Andrea Kistner
Bedrijven | Functie | Begin |
---|---|---|
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Financieel Directeur/CFO | 01-01-2020 |
Eerdere bekende functies van Andrea Kistner
Bedrijven | Functie | Einde |
---|---|---|
Roxiticus Ventures LLC
![]() Roxiticus Ventures LLC Investment ManagersFinance Founded in 2001 by Richard DeSimone, Roxiticus Ventures LLC is a venture capital firm located in Cedar Knolls, New Jersey. | Corporate Officer/Principal | 31-01-2006 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Roxiticus Ventures LLC
![]() Roxiticus Ventures LLC Investment ManagersFinance Founded in 2001 by Richard DeSimone, Roxiticus Ventures LLC is a venture capital firm located in Cedar Knolls, New Jersey. | Finance |
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |